Deerfield Management’s Foamix Pharmaceuticals FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-234,745
Closed -$1.34M – 115
2018
Q3
$1.34M Sell
234,745
-439,257
-65% -$2.51M 0.05% 100
2018
Q2
$3.38M Hold
674,002
– – 0.12% 103
2018
Q1
$3.46M Buy
674,002
+173,002
+35% +$1.04M 0.12% 101
2017
Q4
$3.01M Sell
501,000
-316,435
-39% -$1.9M 0.12% 87
2017
Q3
$4.54M Hold
817,435
– – 0.2% 80
2017
Q2
$3.79M Hold
817,435
– – 0.2% 71
2017
Q1
$4.05M Sell
817,435
-415,409
-34% -$4M 0.16% 89
2016
Q4
$13.7M Sell
1,232,844
-74,214
-6% -$698K 0.56% 54
2016
Q3
$12.1M Buy
1,307,058
+25,000
+2% +$209K 0.56% 44
2016
Q2
$8.14M Buy
1,282,058
+333,124
+35% +$2.21M 0.32% 60
2016
Q1
$6.19M Hold
948,934
– – 0.26% 66
2015
Q4
$7.7M Hold
948,934
– – 0.31% 69
2015
Q3
$6.96M Hold
948,934
– – 0.27% 80
2015
Q2
$9.7M Buy
948,934
+269,307
+40% +$2.98M 0.32% 72
2015
Q1
$6.29M Sell
679,627
-65,172
-9% -$583K 0.2% 79
2014
Q4
$5.22M Buy
744,799
+298,347
+67% +$1.71M 0.19% 80
2014
Q3
$2.43M Buy
+446,452
New +$2.56M 0.09% 108

Other funds holding FOMX

Deerfield Management's FOMX Position: Q4 2018 in Review

Deerfield Management sold out of Foamix Pharmaceuticals (FOMX) in Q4 2018, closing a stake of 234,745 shares — an estimated $1.34M sold.

Deerfield Management first reported a position in FOMX in Q3 2014 and held it in 17 quarters. The position peaked at $13.7M in Q4 2016. 66 funds tracked by Wall St. Rank hold FOMX as of Q4 2018.

  • Deerfield Management reported no remaining Foamix Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Deerfield Management sold 234,745 Foamix Pharmaceuticals shares in Q4 2018, an estimated $1.34M.
  • Deerfield Management first reported a position in Foamix Pharmaceuticals in Q3 2014 and held it in 17 quarters.
  • Deerfield Management's Foamix Pharmaceuticals position peaked at $13.7M in Q4 2016.
  • 66 funds tracked by Wall St. Rank held Foamix Pharmaceuticals as of Q4 2018.

Based on Deerfield Management's 13F filing for Q4 2018, filed 14 Feb 2019.